Neuropsychological impairments predict the clinical course in schizophrenia

European Archives of Psychiatry and Clinical Neuroscience

Volumn 258, Issue SUPPL. 5, 2008, Pages 28-34

  Wölwer, Wolfgang ^a   Brinkmeyer, Jürgen ^a   Riesbeck, Mathias ^a   Freimüller, Lena ^a   Klimke, Ansgar ^b   Wagner, Michael ^c   Möller, Hans Jürgen ^d   Klingberg, Stefan ^e   Gaebel, Wolfgang ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Offenbach Clinic   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cognition; Neuropsychology; Outcome; Prediction; Schizophrenia

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; FEMALE; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MALE; MENTAL PATIENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE;

ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; ROC CURVE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 55449110677     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-008-5006-2     Document Type: Conference Paper

References (55)

1. M Albus W Hubmann J Scherer B Dreikorn S Hecht N Sobizack F Mohr 2002 A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia Eur Arch Psychiatry Clin Neurosci 252 262 267
2. Aster M, Neubauer A, Horn R (2006) Wechsler Intelligenztest für Erwachsene (WIE). Harcourt Test Services, Frankfurt
3. Bilder RM, Bates JA (1994) Neuropsychological prediction of treatment response and outcome in schizophrenia. In: Gaebel W, Awad AG (eds) Prediction of neuroleptic treatment outcome in schizophrenia: concepts and methods. Springer, New York, pp 99-110
4. CR Bowie WW Leung A Reichenberg MM McClure TL Patterson RK Heaton PD Harvey 2008 Predicting schizophrenia patients' real world behavior with specific neuropsychological and functional capacity measures Biol Psychiatry 63 505 511
5. DL Braff TA Greenwood NR Swerdlow GA Light NJ Schork 2008 Advances in endophenotyping schizophrenia World Psychiatry 7 11 18
6. JS Brekke JD Long N Nesbitt E Sobel 1997 The impact of service characteristics on functional outcomes from community support programs for persons with schizophrenia: a growth curve analysis J Consult Clin Psychol 65 464 475
7. WJ Brewer SM Francey SJ Wood HJ Jackson C Pantelis LJ Phillips AR Yung VA Anderson PD McGorry 2005 Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis Am J Psychiatry 162 71 78
8. PF Buckley PD Harvey CR Bowie A Loebel 2007 The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone Schizophr Res 94 99 106
9. TD Cannon LE Zorrilla D Shtasel RE Gur RC Gur EJ Marco P Moberg RA Price 1994 Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers Arch Gen Psychiatry 51 651 661
10. B Cornblatt M Obuchowski S Roberts S Pollack L Erlenmeyer-Kimling 1999 Cognitive and behavioral precursors of schizophrenia Dev Psychopathol 11 487 508
11. BA Cornblatt NJ Risch G Faris D Friedman L Erlenmeyer-Kimling 1988 The continuous performance test, identical pairs version (CPT-IP): I new findings about sustained attention in normal families Psychiatry Res 26 223 238
12. R Cosway M Byrne R Clafferty A Hodges E Grant SS Abukmeil SM Lawrie P Miller EC Johnstone 2000 Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study Psychol Med 30 1111 1121
13. JG Csernansky R Mahmoud R Brenner 2002 A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia N Engl J Med 346 16 22
14. MJ Cuesta V Peralta A Zarzuela 1998 Ilness duration and neuropsychological impairments in schizophrenia Schizophr Res 33 141 150
15. C Demily N Franck 2008 Cognitive remediation: a promising tool for the treatment of schizophrenia Expert Rev Neurother 8 1029 1036
16. B Elvevåg TE Goldberg 2000 Cognitive impairment in schizophrenia is the core of the disorder Crit Rev Neurobiol 14 1 21
17. R Emsley B Chiliza R Schoeman 2008 Predictors of long-term outcome in schizophrenia Curr Opin Psychiatry 21 173 177
18. Frances A, Pincus HA, First MB (1994) The global assessment of functioning scale (GAF). In: Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington DC, p 34
19. R Fuller P Nopoulos S Arndt D O'Leary BC Ho NC Andreasen 2002 Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance Am J Psychiatry 159 1183 1189
20. W Gaebel M Jänner N Frommann A Pietzcker W Köpcke M Linden P Müller F Müller-Spahn J Tegeler 2002 First vs. multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies Schizophr Res 53 145 159
21. W Gaebel HJ Möller G Buchkremer C Ohmann M Riesbeck W Wölwer M Von Wilmsdorff R Bottlender S Klingberg 2004 Pharmacological long-term treatment strategies in first episode schizophrenia: study design and preliminary results of an ongoing RCT within the german research network on schizophrenia Eur Arch Psychiatry Clin Neurosci 254 129 140
22. W Gaebel M Riesbeck W Wölwer A Klimke M Eickhoff M von Wilmsdorff MC Jockers-Scherübl KU Kühn M Lemke A Bechdolf S Bender D Degner R Schlösser LG Schmidt A Schmitt M Jäger G Buchkremer P Falkai S Klingberg W Köpcke W Maier H Häfner C Ohmann HJ Salize F Schneider HJ Möller German Study Group on First-Episode Schizophrenia 2007 Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German research network on schizophrenia J Clin Psychiatry 68 1763 1774
23. JM Gold C Carpenter C Randolph TE Goldberg DR Weinberger 1997 Auditory working memory and Wisconsin card sorting test performance in schizophrenia Arch Gen Psychiatry 54 159 165
24. RW Gråwe S Levander 2001 Neuropsychological impairments in patients with schizophrenia: stability and prediction of outcome Acta Psychiatr Scand Suppl 408 60 64
25. MF Green 2006 Cognitive impairment and functional outcome in schizophrenia and bipolar disorder J Clin Psychiatry 67 Suppl 9 3 8
26. MF Green RS Kern DL Braff J Mintz 2000 Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 26 119 136
27. RE Gur ME Calkins RC Gur WP Horan KH Nuechterlein LJ Seidman WS Stone 2007 The consortium on the genetics of schizophrenia: neurocognitive endophenotypes Schizophr Bull 33 49 68
28. Guy W (ed) (1976) Clinical global impression (CGI). In: ECDEU assessment manual for psychopharmacology, Rev. edn. US Department of Health, Education and Welfare, Washington, DC
29. PD Harvey H Bertisch JI Friedman S Marcus M Parrella L White KL Davis 2003 The course of functional decline in geriatric patients with schizophrenia: cognitive-functional and clinical symptoms as determinants of change Am J Geriatr Psychiatry 11 610 619
30. RW Heinrichs KK Zakzanis 1998 Neurocognitive deficit in schizophrenia: a quantative review of the evidence Neuropsychol 12 426 445
31. Helmstaedter C, Lendt M, Lux S (2001) Verbaler Lern- und Merkfähigkeitstest. Göttingen, Hogrefe
32. AL Hoff C Svetina G Shields J Stewart LE DeLisi 2005 Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia Schizophr Res 78 27 34
33. EAE Holthausen D Wiersma W Cahn RS Kahn PM Dingemans AH Schene RJ van den Bosch 2007 Predictive value of cognition for different domains of outcome in recent-onset schizophrenia Psychiatry Res 149 71 80
34. SR Kay LA Opler A Fiszbein 1986 The positive and negative syndrome scale (PANSS) rating manual Soc Behav Sci Doc 17 28 29
35. RS Keefe CE Eesley MP Poe 2005 Defining a cognitive function decrement in schizophrenia Biol Psychiatry 57 688 691
36. RS Keefe DO Perkins RB Gu Hongbin Zipursky BK Christensen JA Lieberman 2006 A longitudinal study of neurocognitive function in individuals at-risk for psychosis Schizophr Res 88 26 35
37. MM Kurtz 2005 Neurocognitive impairment across the lifespan in schizophrenia: an update Schizophr Res 74 15 26
38. Lehrl S (2005) Mehrfachwahl-Wortschatz-Intelligenztest MWT-B. Spitta Verlag, Balingen
39. T Lencz CW Smith D McLaughlin A Auther E Nakayama L Hovey BA Cornblatt 2005 Generalized and specific neurocognitive deficits in prodromal schizophrenia Biol Psychiatry 59 863 871
40. P Milev BC Ho S Arndt NC Andreasen 2005 Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up Am J Psychiatry 162 495 506
41. S Moritz M Krausz E Gottwalz M Lambert C Perro S Ganzer D Naber 2000 Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics Psychopathology 33 48 51
42. JP O'Donnell LA Macgregor JJ Dabrowski JM Oestreicher JJ Romero 1994 Construct validity of neuropsychological tests of conceptual and attentional abilities J Clin Psychol 50 596 600
43. M Petrides B Milner 1982 Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man Neuropsychologia 20 249 262
44. RM Reitan 1958 Validity of the trail making test as an indicator of organic brain damage Percept Mot Skills 8 271 276
45. D Robinson MG Woerner JMJ Alvir R Bilder R Goldman S Geisler A Koreen B Sheitman M Chakos D Mayerhoff JA Lieberman 1999 Predictors of relapse following response form a first episode of schizophrenia or schizoaffective disorder Arch Gen Psychiatry 56 241 247
46. BR Rund 1998 A review of longitudinal studies of cognitive functions in schizophrenia patients Schizophr Bull 24 425 435
47. AJ Saykin DL Shtasel RE Gur DB Kester LH Mozley P Stafiniak RC Gur 1994 Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia Arch Gen Psychiatry 51 124 131
48. D Schüpbach MS Harris MS Keshavan JA Sweeney 2007 Die Bedeutung der Negativsymptomatik für kognitive Defizite bei Patienten mit Erstmanifestation einer Schizophrenie Schweiz Arch Neurol Psychiatr 185 32 38
49. BE Snitz AW MacDonald CS Carter 2006 Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes Schizophr Bull 32 179 194
50. J Stirling C White S Lewis R Hopkins D Tantam A Huddy L Montague 2003 Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort Schizophr Res 65 75 86
51. A Szöke A Trandafir ME Dupont A Meary F Schürhoff M Leboyer 2008 Longitudinal studies of cognition in schizophrenia: meta analysis Br J Psychiatry 192 248 257
52. DI Velligan CC Bow-Thomas RK Mahurin AL Miller LC Halgunseth 2000 Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? J Nerv Ment Dis 188 518 524
53. MC Whyte C Brett LK Harrison M Byrne P Miller SM Lawrie EC Johnstone 2006 Neuropsychological performance over time in people at high risk of developing schizophrenia and controls Biol Psychiatry 59 730 739
54. A Wittorf G Wiedemann G Buchkremer S Klingberg 2008 Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment Eur Arch Psychiatry Clin Neurosci 258 48 58
55. W Wölwer G Buchkremer H Häfner J Klosterkötter W Maier HJ Möller W Gaebel 2003 German research network on schizophrenia-bridging the gap between research and care Eur Arch Psychiatry Clin Neurosci 253 321 329